INTRINSIC LYMPHOCYTE-B DEFECT IN UNTREATED PATIENTS WITH HODGKINS-DISEASE

被引:3
作者
GRIESINGER, F
BERGMANN, L
BAROTCIORBARU, R
MITROU, PS
机构
[1] UNIV FRANKFURT, DEPT INTERNAL MED, DIV HEMATOL ONCOL, THEODOR STERN KAI 7, W-6000 FRANKFURT, GERMANY
[2] UNIV PARIS 11, INST BIOCHEM, F-91405 ORSAY, FRANCE
关键词
D O I
10.1007/BF01741710
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In vivo and in vitro humoral and cell-mediated immunological defects have been described in untreated patients with Hodgkin's disease (HD). The cellular basis of the recently described in vitro reduction of mitogen-induced immunoglobulin synthesis has not been elucidated so far. In this study, we attempted to dissect T and B lymphocyte function in untreated HD patients. Mitogen-induced in vitro immunoglobulin synthesis was assessed in the presence of pokeweed mitogen, the mitogenic anti-CD3 monoclonal antibody OKT3 and the relatively T-cell-independent B cell mitogen Nocardia opaca delipidated mitogen (NDCM). Mitogen-induced Ig synthesis by HD peripheral blood mononuclear cells was significantly reduced compared to that in control peripheral blood mononuclear cells. In coculture assays, T cells of HD patients exerted an adequate helper function to control B cells. However, normal donor T cells did not restore Ig synthesis by B cells of HD patients. Finally, B cells of HD patients were unresponsive to NDCM, which is able to induce Ig synthesis in control B cells even in the absence of T cells. These data provide evidence for an intrinsic functional B lymphocyte defect in HD patients, and suggest that increased activation of suppressor HD T lymphocytes may not play a significant role in the suppression of in vitro Ig synthesis © 1990 Springer-Verlag.
引用
收藏
页码:256 / 260
页数:5
相关论文
共 38 条
[1]  
AISENBERG AC, 1966, CANCER-AM CANCER SOC, V19, P385, DOI 10.1002/1097-0142(196603)19:3<385::AID-CNCR2820190312>3.0.CO
[2]  
2-S
[3]  
AISENBERG AC, 1966, CANCER RES, V26, P1152
[4]   FUNCTIONAL AND MOLECULAR ASPECTS OF HUMAN LYMPHOCYTE-T ACTIVATION VIA T3-TI-PATHWAYS AND T11-PATHWAYS [J].
ALCOVER, A ;
RAMARLI, D ;
RICHARDSON, NE ;
CHANG, HC ;
REINHERZ, EL .
IMMUNOLOGICAL REVIEWS, 1987, 95 :5-36
[5]  
BAROTCIORBARU R, 1981, J RETICULOENDOTH SOC, V30, P247
[6]   ENHANCEMENT OF NATURAL-KILLER CELL-ACTIVITY BY NOCARDIA-OPACA FRACTIONS [J].
BAROTCIORBARU, R ;
LINNA, TJ ;
PATEL, MR ;
ALTMAN, J ;
CARNAUD, C .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1989, 29 (02) :133-141
[7]  
BAROTCIORBARU R, 1985, J IMMUNOL, V135, P3277
[8]  
BERGMANN L, 1987, CANCER IMMUNOL IMMUN, V25, P59
[9]   POLYCLONAL ACTIVATION OF HUMAN LYMPHOCYTES-B BY NOCARDIA WATER-SOLUBLE MITOGEN (NWSM) [J].
BONA, C ;
BRODER, S ;
DIMITRIU, A ;
WALDMANN, TA .
IMMUNOLOGICAL REVIEWS, 1979, 45 :69-92
[10]  
Bona C, 1979, Prog Allergy, V26, P97, DOI 10.1159/000314462